Trial Profile
Long-term study of K-877
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Kowa
- 09 Jun 2016 New trial record